{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:23:59Z","timestamp":1737696239696,"version":"3.33.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,23]]},"DOI":"10.7759\/cureus.77879","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T19:48:15Z","timestamp":1737661695000},"source":"Crossref","is-referenced-by-count":0,"title":["Advancing Pyoderma Gangrenosum Management With a Multidisciplinary Approach"],"prefix":"10.7759","author":[{"given":"Martena","family":"Grace","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir A","family":"Estil-las","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Arsene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042440","article-title":"The pathophysiology and treatment of pyoderma gangrenosum-current options and new perspectives","volume":"25","author":"\u0141yko M","year":"2024","unstructured":"\u0141yko M, Rygu\u0142a A, Kowalski M, Karska J, Jankowska-Konsur A. The pathophysiology and treatment of pyoderma gangrenosum-current options and new perspectives. Int J Mol Sci. 2024, 25:2440. 10.3390\/ijms25042440","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.001","article-title":"Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis","volume":"83","author":"Xu A","year":"2020","unstructured":"Xu A, Balgobind A, Strunk A, Garg A, Alloo A. Prevalence estimates for pyoderma gangrenosum in the United States: an age- and sex-adjusted population analysis. J Am Acad Dermatol. 2020, 83:425-9. 10.1016\/j.jaad.2019.08.001","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01931-3","article-title":"Pyoderma gangrenosum: treatment options","volume":"83","author":"Dissemond J","year":"2023","unstructured":"Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG. Pyoderma gangrenosum: treatment options. Drugs. 2023, 83:1255-67. 10.1007\/s40265-023-01931-3","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller J","year":"2010","unstructured":"Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010, 62:646-54. 10.1016\/j.jaad.2009.05.030","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus AM","year":"2011","unstructured":"Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011, 165:1244-50. 10.1111\/j.1365-2133.2011.10565.x","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.7.861","article-title":"Poor prognosis of arthritis-associated pyoderma gangrenosum","volume":"140","author":"Charles CA","year":"2004","unstructured":"Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS. Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol. 2004, 140:861-4. 10.1001\/archderm.140.7.861","journal-title":"Arch Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241238713","article-title":"Evaluating the clinical utility of sulfasalazine in the treatment of pyoderma gangrenosum: a systematic review","volume":"28","author":"Zabihi H","year":"2024","unstructured":"Zabihi H, Shojaei D, Seigel K, Al-Dehneem R, Piguet V, Croitoru DO. Evaluating the clinical utility of sulfasalazine in the treatment of pyoderma gangrenosum: a systematic review. J Cutan Med Surg. 2024, 28:289-91. 10.1177\/12034754241238713","journal-title":"J Cutan Med Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13173","article-title":"Treatment options for pyoderma gangrenosum","volume":"15","author":"Quist SR","year":"2017","unstructured":"Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. J Dtsch Dermatol Ges. 2017, 15:34-40. 10.1111\/ddg.13173","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/ASW.0000000000000092","article-title":"Wound debridement in pyoderma gangrenosum","volume":"37","author":"Taheri A","year":"2024","unstructured":"Taheri A, Mansoori P, Sharif M. Wound debridement in pyoderma gangrenosum. Adv Skin Wound Care. 2024, 37:107-11. 10.1097\/ASW.0000000000000092","journal-title":"Adv Skin Wound Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335808-advancing-pyoderma-gangrenosum-management-with-a-multidisciplinary-approach","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T19:48:17Z","timestamp":1737661697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335808-advancing-pyoderma-gangrenosum-management-with-a-multidisciplinary-approach"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.77879","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,23]]}}}